News
Three Months After $28.6M PIPE, Telesta Shares Fall on FDA Panel Vote
|
Three months after Telesta Therapeutics (TST.TO) raised $28.6 million in a private placement of stock, the company’s shares lost almost 40% of their value when a Food and Drug Administration advisory panel expressed a negative view of a drug Telesta is developing.



